{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:37:08Z","timestamp":1762605428345},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T00:00:00Z","timestamp":1179187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,14]]},"DOI":"10.1007\/s10067-007-0643-9","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T07:01:12Z","timestamp":1179126072000},"page":"1711-1715","source":"Crossref","is-referenced-by-count":44,"title":["Rituximab for treatment-resistant extensive Wegener`s granulomatosis\u2014additive effects of a maintenance treatment with leflunomide"],"prefix":"10.1007","volume":"26","author":[{"given":"J. C.","family":"Henes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Horger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Risler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Koetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,15]]},"reference":[{"key":"643_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener\u2019s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"643_CR2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","volume":"368","author":"X Bosch","year":"2006","unstructured":"Bosch X, Guilabert A, Font J (2006) Antineutrophil cytoplasmatic antibodies. Lancet 368:404\u2013418","journal-title":"Lancet"},{"key":"643_CR3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"643_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"643_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(90)90367-M","volume":"89","author":"GS Hoffman","year":"1990","unstructured":"Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS (1990) Treatment of Wegener\u2019s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 89:403\u2013410","journal-title":"Am J Med"},{"key":"643_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"WGET Research Group","year":"2005","unstructured":"WGET Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352:351\u2013361","journal-title":"N Engl J Med"},{"key":"643_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/keh009","volume":"43","author":"C Metzler","year":"2004","unstructured":"Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E (2004) Maintenance of remission with leflunomide in Wegener\u2019s granulomatosis. Rheumatology 43:315\u2013320","journal-title":"Rheumatology"},{"key":"643_CR8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","volume":"48","author":"GJ Silverman","year":"2003","unstructured":"Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 48:1484\u20131492","journal-title":"Arthritis Rheum"},{"issue":"1","key":"643_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","volume":"52","author":"KA Keogh","year":"2005","unstructured":"Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U (2005) Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(1):262\u2013268","journal-title":"Arthritis Rheum"},{"issue":"12","key":"643_CR10","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","volume":"44","author":"U Specks","year":"2001","unstructured":"Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener\u2019s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44(12):2836\u20132840","journal-title":"Arthritis Rheum"},{"issue":"6","key":"643_CR11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","volume":"257","author":"P Eriksson","year":"2005","unstructured":"Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257(6):540\u2013548","journal-title":"J Intern Med"},{"issue":"11","key":"643_CR12","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","volume":"45","author":"R Stasi","year":"2006","unstructured":"Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D (2006) Long term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45(11):1432\u20131436","journal-title":"Rheumatology (Oxford)"},{"key":"643_CR13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U et al (2001) A disease-specific Activity index for Wegener\u2019s granulomatosis. Arthritis Rheum 44:912\u2013920","journal-title":"Arthritis Rheum"},{"issue":"7","key":"643_CR14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","volume":"65","author":"PM Aries","year":"2006","unstructured":"Aries PM, Hellmich B, Voswinkel J, Both M, Noelle B, Holl-Ulrich K et al (2006) Lack of efficacy of Rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 65(7):853\u2013858","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"643_CR15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","volume":"54","author":"P Emery","year":"2006","unstructured":"Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A et al. and DANCER Study Group (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54(5):1390\u20131400","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0643-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0643-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:07Z","timestamp":1559105467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0643-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,15]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,14]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0643-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,15]]}}}